Johnson & Johnson JNJ Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $21.04B-21.5% | $26.8B+6.7% | $25.12B+10.8% | $22.66B+3.9% | $21.81B+55.1% | ||
| $7.74B+3.1% | $7.5B+1.6% | $7.39B-0.9% | $7.46B+2.2% | $7.3B-0.6% | ||
| $1.37B+0.9% | $1.35B+5.5% | $1.28B+4.2% | $1.23B+5.9% | $1.16B-1.2% | ||
| $22.87B-6.8% | $24.53B+1.3% | $24.2B+5.1% | $23.03B-7.1% | $24.78B+2.1% | ||
| $5.09B+5.3% | $4.83B+4.9% | $4.61B+2.9% | $4.48B+1.5% | $4.41B-0.3% | ||
| —— | $17.5B+21.0% | $14.46B-2.3% | $14.8B+11.0% | $13.34B-12.0% | ||
| -$24.33B-3.1% | -$23.59B-15.5% | -$20.42B+11.2% | -$23.01B-24.8% | -$18.43B+0.9% | ||
| $7.85B+31.9% | $5.95B+38.1% | $4.31B+46.2% | $2.95B-4.4% | $3.08B+26.8% | ||
| —— | —— | —— | —— | $15.8B+137% | ||
| -$15.43B-179% | -$5.54B-0.5% | -$5.51B+14.8% | -$6.47B-196% | $6.74B+315% | ||
| —— | —— | -$1.75B+72.2% | -$6.3B— | —— | ||
| $17.78B-9.7% | $19.7B+0.5% | $19.6B+5.6% | $18.55B-8.9% | $20.37B+2.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Johnson & Johnson generate?
- Johnson & Johnson (JNJ) generated $22.9B in operating cash flow over the trailing twelve months.
- What is Johnson & Johnson's free cash flow?
- After $5.1B of capital expenditures, Johnson & Johnson's free cash flow was $17.8B over the trailing twelve months, down 12.7% year over year.
- Where does Johnson & Johnson's cash flow data come from?
- Every line is extracted from Johnson & Johnson's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
